Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Sep 29;114(39):660.
doi: 10.3238/arztebl.2017.0660b.

Further Symptoms of Sjögren's Syndrome

Holger Kiesewetter
Comment

Further Symptoms of Sjögren's Syndrome

Holger Kiesewetter. Dtsch Arztebl Int. .
No abstract available

PubMed Disclaimer

Comment in

  • In Reply.
    Stefanski AL. Stefanski AL. Dtsch Arztebl Int. 2017 Sep 29;114(39):660-661. doi: 10.3238/arztebl.2017.0660c. Dtsch Arztebl Int. 2017. PMID: 29034870 Free PMC article. No abstract available.

Comment on

  • The Diagnosis and Treatment of Sjögren's Syndrome.
    Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T. Stefanski AL, et al. Dtsch Arztebl Int. 2017 May 26;114(20):354-361. doi: 10.3238/arztebl.2017.0354. Dtsch Arztebl Int. 2017. PMID: 28610655 Free PMC article. Review.

References

    1. Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T. The diagnosis and treatment of Sjögren’s syndrome. Dtsch Arztebl Int. 2017;114:354–361. - PMC - PubMed
    1. Decousus H, Prandoni P, Mismetti P, et al. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med. 2010;363:1222–1232. - PubMed
    1. Haji-Mihailovic M, Jankovic L, Cakic S. Circulating immune complexes, immunoglobulin G, salivary proteins and salivary immunoglobulin A in patients with Sjögren’s syndrome. Srp Arh Celok Lek. 2009;137:134–139. - PubMed
    1. Corominas H, Ortiz-Santamaría V, Castellví I, et al. Nailfold capillaroscopic findings in primary Sjögren‘s syndrome with and without Raynaud‘s phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies. Rheumatol Int. 2016;36:365–369. - PubMed